Twist Bioscience's Chief Legal: What Investors Need to Know
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
Explore the differences between zero based and traditional budgeting to find the best fit for your financial needs. Make your budgeting work for you.
19,711 articlesA senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
A disciplined Thursday reads habit can turn noise into signals. This guide curates practical thursday reads, explains...
CrowdStrike is moving to a 4-for-1 stock split. This guide breaks down what the split does, how it affects you as an ...
A message that seems to come from the boss can trigger a chain of costly actions. This guide breaks down how these sc...
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Amazon is moving deeper into custom AI chips, challenging Nvidia’s data-center dominance. This guide explains how ama...
Europe confronts a rocket shortage leaves europe that threatens space infrastructure, defense planning, and private i...
Copart director Daniel Englander recently sold 80,000 shares for about $2.2 million. With CPRT down roughly 40%, inve...
Senate Democrats allege the White House granted tariff exemptions to firms tied to donors, sparking a bipartisan push...
Tilray’s stock has been a rollercoaster, but deciding whether to time dump your shares depends on your portfolio, ris...
This fresh analysis explores intuit (intu) 2026 earnings, highlighting key growth drivers, profitability advances, an...
As CPS Tech nears its Q4 2025 results, investors seek clarity on revenue, margins, and strategy. This guide breaks do...